
Work Here?
Wellinks provides a connected, digital solution for COPD care that brings together devices, a patient app, and personalized coaching to support disease management. The platform collects real‑time data from connected devices and the app, uses it to tailor coaching and enable remote monitoring, and is offered as a subscription service to patients, healthcare providers, and payers. Unlike other digital health tools, Wellinks combines hardware, software, and coaching in a single integrated program that can be deployed across healthcare teams and payer networks as a service. Its goal is to improve COPD outcomes and patient empowerment while reducing costs by enabling ongoing, remote care and closer collaboration among patients, clinicians, and payers.
Industries
Enterprise Software
Healthcare
Company Size
11-50
Company Stage
Series B
Total Funding
$48.7M
Headquarters
New Haven, Connecticut
Founded
2013
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$48.7M
Below
Industry Average
Funded Over
6 Rounds
Industry standards
Wellinks raises $10M Series B. Wellinks raises $10M in Series B funding led by UMass Memorial Health to expand its cardiopulmonary remote patient monitoring platform. Updated August 07, 2026 Wellinks, based in New Haven, Connecticut, is a digital health provider specializing in cardiopulmonary remote patient monitoring. The company has secured $10M as the first tranche of its Series B funding round. Investors. The funding round was led by strategic partner UMass Memorial Health, with participation from existing inside investors. Wellinks use of funds. Capital proceeds will be used to expand the company's commercial footprint into rural and underserved markets, advance their predictive analytics engines, and extend their care model into the treatment of Congestive Heart Failure. About Wellinks. Founded in New Haven, Wellinks provides an FDA-cleared remote patient monitoring system and proprietary health tags that deliver continuous physiological tracking to predict clinical deterioration in patients, specifically targeting conditions like COPD. Funding details. Company: Wellinks Raised: $10M Round: Series B Funding Date: August 5, 2026 Lead Investor: UMass Memorial Health Additional Investors: Existing inside investors Software Category: Digital Health Source: https://ramaonhealthcare.com/wellinks-raises-10m-to-scale-predictive-cardiopulmonary-remote-patient-monitoring/ Updated August 07, 2026
Wellinks raises $10M in Series B funding. August 5, 2026 Wellinks, a New Haven, CT-based cardiopulmonary care platform provider, raised $10M in the first close of its Series B funding. Backers included UMass Memorial Health and other investors. The company intends to use the funds to: * Expand its commercial footprint. * Advance its predictive capabilities. * Expand into additional cardiopulmonary conditions. Led by Interim CEO and Chief Operating Officer Jennifer Barretta, Wellinks provides a virtual cardiopulmonary care platform that pairs virtual chronic disease management with remote patient monitoring. The solution uses the proprietary, FDA-cleared Spire Remote Patient Monitoring (RPM) System and Health Tags to provide passive, continuous monitoring that identifies early physiologic changes and predicts clinical deterioration up to one week before symptom onset, enabling earlier clinical intervention and reducing acute care utilization. Don't just read the news. Own the data. Stop manually tracking deals. Access this round and over 100 others this week - in our structured Master Database (XML) + Weekly Intelligence PDF. [Access FinSMEs Intelligence Hub] 05/08/2026
Wellinks, a cardiopulmonary care company, has closed the first tranche of its Series B funding round, raising $10 million from UMass Memorial Health and existing investors. The investment builds on Wellinks' partnership with UMass Memorial Health to expand its predictive care solution. Wellinks' FDA-cleared Spire Remote Patient Monitoring System identifies early physiological changes associated with clinical deterioration in chronic respiratory disease patients. A study with UMass Chan Medical School found that participants had over 60% lower odds of 30-day hospital readmission. The funding will support commercial expansion into underserved communities, advance predictive capabilities using real-world clinical data, and extend the technology to additional cardiopulmonary conditions including congestive heart failure.
Top 10 healthcare services capital raises and investors in the U.S. - november 16th to December 31st, 2025. Several interesting transactions closed in the HealthCare Services sector over the past month. If you would like more info or would like to discuss the capital raising market for your company, please contact me. * JoyBridge Kids, clinics intended for children with autism, received $2.5 million of development capital from investors. * Wellinks, virtual pulmonary care service for people with chronic respiratory disease, especially chronic obstructive pulmonary disease, received $5.90 million of development capital from investors. * Crespo Injury Care Center, comprehensive injury care services for auto accident victims and sports injury patients in Tampa, Florida, was acquired by Physician Partners of America. * Danner Laboratory, clinical laboratory and diagnostic testing services that provide accurate, timely molecular, cytology, and pathology results for healthcare providers and patients, was acquired by Leo International Precision Health. * Angle Health, health insurance platform for personalized healthcare management, raised $134 million through a combination of Series B venture funding in a deal led by Portage on December 3, 2025, putting the company's pre-money valuation at $549 million. * B Positive, plasma collection company that allows donors to donate their blood plasma for life-saving medical therapies, raised $163,870 of venture funding. * Clarity Pediatrics, pediatric telehealth platform that provides access to high-quality ADHD (Attention-deficit/hyperactivity disorder) care for children and families, raised $14.45 million through a combination of Series A-1 and Series A-2 venture funding in a deal led by Jackson Square Ventures, putting the company's pre-money valuation at $29.05 million. * Full Bloom Memory Care, dementia care services that specialize in one-on-one memory care at home and comprehensive support for families dealing with cognitive changes, raised $500,000 of venture funding from investors, putting the company's pre-money valuation at $3.5 million. * DesiCorp, freeze-dried red blood cell technology that offers a proper method to extend the shelf-life of blood, raised $5 million of Seed-2 funding from Keyhorse Capital, and other investors, putting the company's pre-money valuation at $27.12 million. * HereNOW Help, comprehensive mental health platform that facilitates personalized treatment and support, raised $2.35 million of seed funding from investors. Anna moisuc. Managing director. Please contact me if you have any questions or would like to discuss your capital raise: Sources: Information on this page was derived from a variety of sources including Bloomberg, Company Websites, Crunchbase, PitchBook and other news outlets. Castle Placement(R) does not warrant or guarantee this information, nor makes any representations as to the accuracy of the information. For more Risks, see CPGO Risks and Disclaimers.
NEW HAVEN, Conn., March 17, 2025 (GLOBE NEWSWIRE) - Wellinks, a digital healthcare company specializing in Chronic Obstructive Pulmonary Disease (COPD) management, today announced a strategic partnership with CareAbout Health, a leading healthcare management company.
Find jobs on Simplify and start your career today
Industries
Enterprise Software
Healthcare
Company Size
11-50
Company Stage
Series B
Total Funding
$48.7M
Headquarters
New Haven, Connecticut
Founded
2013
Find jobs on Simplify and start your career today